Video

Treating Cerebrovascular Lesions a Matter of Choice and Data Driven Decisions

Author(s):

In the past year there has been a large amount of discussion about the best ways to treat stroke patients. While operations have become more accepted there are other less invasive steps that can be taken as well.

In the past year there has been a large amount of discussion about the best ways to treat stroke patients. While operations have become more accepted there are other less invasive steps that can be taken as well.

Seeing a patient with a vascular lesion can present maultiple challenges for doctors. How they choose to treat them can be as difficult as the diagnosis process itself. For veteran doctors used to taking a certain course of treatment over the course of their careers adopting new options can be a difficult proposition. At the same time those doctors recently out of medical school may have a better understanding of the technology available to them, but not the institutional knowledge of how treatment was handled at a time when there were little or no options to help people.

Antonio Culebras, MD, from SUNY Upstate University Hospital discussed these topics and more during the 2015 American Academy of Neurology's annual meeting in Washington DC.

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.